Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma

被引:34
作者
Leung, Alan S. [1 ,3 ]
Rath, Tanya J. [1 ]
Hughes, Marion A. [1 ]
Kim, Seungwon [2 ]
Branstetter, Barton F. [1 ,2 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Radiol, 200 Lothrop St,8619 Presby South Tower,Wing 8N, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15213 USA
[3] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2016年 / 38卷
关键词
fluorodeoxyglucose (FDG); positron emission tomography (PET)/CT; head and neck squamous cell carcinoma; posttreatment; timing; POSITRON-EMISSION-TOMOGRAPHY; RADIATION-THERAPY; CANCER; SURVEILLANCE; CHEMORADIOTHERAPY; RADIOTHERAPY; RECURRENCE;
D O I
10.1002/hed.24112
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The optimal timing for the initial posttreatment fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT scan after definitive treatment of head and neck squamous cell carcinoma (HNSCC) is unclear. Methods. We conducted a retrospective review of 247 patients with definitively treated nonmetastatic HNSCC. First posttreatment PET/CT scans were grouped into: <7 weeks, 7 to 10 weeks, 11 to 14 weeks, and >= 15 weeks. Scans were categorized as positive or negative and accuracy of scans was calculated for each group using biopsy, subsequent imaging, or clinical follow-up for 1 year after treatment as a reference standard. Results. Sixty-seven of the 247 patients (27.1%) had treatment failure. Scans performed at <7 weeks were less accurate than all other time intervals (p < .05). Scans performed at all other intervals were similar in accuracy. Conclusion. First posttreatment PET/CT can be obtained as early as 2 months after therapy. Scans performed earlier than 2 months have lower accuracy. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E853 / E858
页数:6
相关论文
共 19 条
[1]   Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up? [J].
Abgral, Ronan ;
Querellou, Solene ;
Potard, Gael ;
Le Roux, Pierre-Yves ;
Le Duc-Pennec, Alexandra ;
Marianovski, Remi ;
Pradier, Olivier ;
Bizais, Yves ;
Kraeber-Bodere, Francoise ;
Salaun, Pierre Y. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) :24-29
[2]   Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers [J].
Andrade, Regiane S. ;
Heron, Dwight E. ;
Degirmenci, Berna ;
Filho, Pedro A. A. ;
Branstetter, Barton F. ;
Seethala, Raja R. ;
Ferris, Robert L. ;
Avril, Norbert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (05) :1315-1322
[3]  
[Anonymous], 2013, NCCN CLIN PARCT GUID
[4]   Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring [J].
Beswick, Daniel M. ;
Gooding, William E. ;
Johnson, Jonas T. ;
Branstetter, Barton F. .
LARYNGOSCOPE, 2012, 122 (07) :1512-1517
[5]   Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial [J].
Bourhis, Jean ;
Sire, Christian ;
Graff, Pierre ;
Gregoire, Vincent ;
Maingon, Philippe ;
Calais, Gilles ;
Gery, Bernard ;
Martin, Laurent ;
Alfonsi, Marc ;
Desprez, Patrick ;
Pignon, Thierry ;
Bardet, Etienne ;
Rives, Michel ;
Geoffrois, Lionel ;
Daly-Schveitzer, Nicolas ;
Sen, Sok ;
Tuchais, Claude ;
Dupuis, Olivier ;
Guerif, Stephane ;
Lapeyre, Michel ;
Favrel, Veronique ;
Hamoir, Marc ;
Lusinchi, Antoine ;
Temam, Stephane ;
Pinna, Antonella ;
Tao, Yun Gan ;
Blanchard, Pierre ;
Auperin, Anne .
LANCET ONCOLOGY, 2012, 13 (02) :145-153
[6]   Head and neck malignancy: Is PET/CT more accurate than PET or CT alone? [J].
Branstetter, BF ;
Blodgett, TM ;
Zimmer, LA ;
Snyderman, CH ;
Johnson, JT ;
Raman, S ;
Meltzer, CC .
RADIOLOGY, 2005, 235 (02) :580-586
[7]   Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer [J].
Greven, KM ;
Williams, DW ;
McGuirt, WF ;
Harkness, BA ;
D'Agostino, RB ;
Keyes, JW ;
Watson, NE .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (11) :942-946
[8]   Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis [J].
Gupta, Tejpal ;
Master, Zubin ;
Kannan, Sadhana ;
Agarwal, Jai Prakash ;
Ghsoh-Laskar, Sarbani ;
Rangarajan, Venkatesh ;
Murthy, Vedang ;
Budrukkar, Ashwini .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (11) :2083-2095
[9]   Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence [J].
Ho, Allen S. ;
Tsao, Gabriel J. ;
Chen, Frank W. ;
Shen, Tianjie ;
Kaplan, Michael J. ;
Colevas, A. Dimitrios ;
Fischbein, Nancy J. ;
Quon, Andrew ;
Quynh-Thu Le ;
Pinto, Harlan A. ;
Fee, Willard E., Jr. ;
Sunwoo, John B. ;
Sirjani, Davud ;
Hara, Wendy ;
Yao, Mike .
CANCER, 2013, 119 (07) :1349-1356
[10]   A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy [J].
Isles, M. G. ;
McConkey, C. ;
Mehanna, H. M. .
CLINICAL OTOLARYNGOLOGY, 2008, 33 (03) :210-222